Disabling Postural Hypotension Complicating Diabetic Autonomic Neuropathy
- 1 November 1991
- journal article
- case report
- Published by Wiley in Diabetic Medicine
- Vol. 8 (9) , 870-874
- https://doi.org/10.1111/j.1464-5491.1991.tb02127.x
Abstract
A 35-year-old Type 1 diabetic man with severe disabling postural hypotension was studied for physiological abnormalities, precipitating factors, and effect of current treatment. A 24-h blood pressure profile indicated a diurnal variation in systolic blood pressure with the lowest values recorded between 0100 and 0600 h, during which the patient often lost consciousness on standing (mean standing systolic pressure 78 mmHg at night vs 105 mmHg in the afternoon, p less than 0.001). Food induced a profound fall in systolic pressure, both while supine and while standing erect. The systolic pressure fall during euglycaemia was 49 mmHg vs 3 mmHg during hypoglycaemia. Plasma noradrenaline and adrenaline levels were low during euglycaemia, but increased during hypoglycaemia. Therapeutic manoeuvres aimed at increasing heart rate (by atrial tachypacing) and reducing the peripheral pooling of blood (vasoconstricting drugs and gravity suit), together with the somatostatin analogue octreotide, proved ineffective. These observations demonstrate the phenomenon of post-prandial exacerbation of postural hypotension in a Type 1 diabetic patient, and indicate that despite failure of conventional methods of treatment, hypoglycaemia increased plasma catecholamines and was effective in abolishing the blood pressure fall on standing.Keywords
This publication has 12 references indexed in Scilit:
- Effect of food intake on cardiovascular control in patients with impaired autonomic functionJournal of Neuroscience Methods, 1990
- Prevention of Glucose-Induced Hypotension by the Somatostatin Analogue Octreotide (Sms 201-995) in Chronic Autonomic Failure: Haemodynamic and Hormonal ChangesClinical Science, 1989
- Ambulatory Blood Pressure and Heart Rate in Diabetic Patients: an Assessment of Autonomic FunctionDiabetic Medicine, 1989
- Hypotensive and sedative effects of insulin in autonomic failure.BMJ, 1987
- TREATMENT OF AUTONOMIC NEUROPATHY WITH A SOMATOSTATIN ANALOGUE SMS-201-995The Lancet, 1986
- Reduced Postprandial Hyperglycemia After Subcutaneous Injection of a Somatostatin-Analogue (SMS 201-995) in Insulin-dependent Diabetes MellitusDiabetes Care, 1985
- Diagnosis and management of diabetic autonomic neuropathy.BMJ, 1982
- Provocation of Postural Hypotension by Insulin in Diabetic Autonomic NeuropathyDiabetes, 1976
- Cardiac Denervation in DiabetesBMJ, 1973
- Plasma Catecholamines in Long-Term Diabetics with and without Neuropathy and in Hypophysectomized SubjectsJournal of Clinical Investigation, 1972